ORI Healthcare Fund Invests in Pillar Biosciences

2016 May 11

ORI Healthcare Fund L.P. (ORI Fund) announces the completion of US$18 million investment into Pillar Biosciences Inc., a Boston-based start-up specialized in next generation sequencing ("NGS")-based clinical oncology testing in order to bring affordable precision medicine to cancer patients globally.

Please see the full press release at MarketWired.